ANIK   $25.475  0.85% Market Open

Anika Therapeutics Inc
Total Cash 62.82M
totalCashPerShare 4.246
EBITDA 11.29M
Total Debt 28.08M
quickRatio 3.698
currentRatio 5.934
Total Revenue 166.88M
debtToEquity 13.348
Revenue/Share 11.349
ROA 0.00011
ROE -0.30629998
grossProfits
freeCashflow 15.75M
operatingCashflow 8.93M
earningsGrowth
revenueGrowth -0.054
grossMargins 0.62611
ebitdaMargins 0.06765
operatingMargins 0.0038400001
profitMargins -0.4445
enterpriseValue 329.85M
forwardPE 107.13043
floatShares 10.78M
sharesOutstanding 14.80M
sharesShort 676.67K
sharesShortPriorMonth 669.18K
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.91%
Short Ratio help_outline 15.25%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 14.175
Price To Book help_outline 1.74
earningsQuarterlyGrowth
netIncomeToCommon -74.18M
trailingEps -5.06%
forwardEps 0.23%
enterpriseToEbitda 29.22
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.03 3Q 2024
institutionsCount 170
lastUpdated Sept. 16, 2024, 12:23 p.m.